First Eagle Investment Management, LLC: ELEVANCE HEALTH INC FORMERLY (ELV): Quarterly 13F Position History
As of Q2 2026, First Eagle Investment Management, LLC reported 4,188,196 shares of ELEVANCE HEALTH INC FORMERLY (ELV), worth $1.6B and representing 2.7% of its 13F equity book. Quarter-over-quarter share count change: + 55,905 (+1.4%) . The position first appeared in Q1 2016 and has been disclosed across 42 13F-HR filings in Pactolio's tracked window.
- 4,188,196Shares Held (Latest Filing)
- $1.6BReported Market Value (Latest Filing)
- 2.7%Portfolio Weight (% of 13F Equity Book)
- +55,905Quarter-over-Quarter Share Change
- +$410.0MQuarter-over-Quarter Value Change
- 4,188,196Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 42 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,188,196 | +55,905 | +1.4% | $1.6B | 2.7% | $386.7 |
| Q1 2026 | 4,132,291 | +109,417 | +2.7% | $1.2B | 1.6% | $292.8 |
| Q4 2025 | 4,022,874 | +24,271 | +0.6% | $1.4B | 2.5% | $350.6 |
| Q3 2025 | 3,998,603 | +798,457 | +25.0% | $1.3B | 2.4% | $323.1 |
| Q2 2025 | 3,200,146 | 41,215 | -1.3% | $1.2B | 2.5% | $389.0 |
| Q1 2025 | 3,241,361 | +16,022 | +0.5% | $1.4B | 3.0% | $435.0 |
| Q4 2024 | 3,225,339 | +1,039,612 | +47.6% | $1.2B | 2.7% | $368.9 |
| Q3 2024 | 2,185,727 | +127,444 | +6.2% | $1.1B | 2.3% | $520.0 |
| Q2 2024 | 2,058,283 | +275,708 | +15.5% | $1.1B | 2.5% | $541.9 |
| Q1 2024 | 1,782,575 | +4,088 | +0.2% | $924.3M | 2.1% | $518.5 |
| Q4 2023 | 1,778,487 | 4,298 | -0.2% | $838.7M | 2.0% | $471.6 |
| Q3 2023 | 1,782,785 | 22,364 | -1.2% | $776.3M | 2.0% | $435.4 |
| Q2 2023 | 1,805,149 | +9,529 | +0.5% | $802.0M | 2.1% | $444.3 |
| Q1 2023 | 1,795,620 | +5,119 | +0.3% | $825.6M | 2.2% | $459.8 |
| Q4 2022 | 1,790,501 | 49,429 | -2.7% | $918.5M | 2.5% | $513.0 |
| Q3 2022 | 1,839,930 | 171,070 | -8.5% | $835.8M | 2.5% | $454.2 |
| Q2 2022 | 2,011,000 | 17,985 | -0.9% | $970.5M | 2.7% | $482.6 |
| Q1 2022 | 2,028,985 | +11,129 | +0.6% | $996.7M | 2.4% | $491.2 |
| Q4 2021 | 2,017,856 | 28,584 | -1.4% | $935.4M | 2.3% | $463.5 |
| Q3 2021 | 2,046,440 | +92,057 | +4.7% | $762.9M | 2.0% | $372.8 |
| Q2 2021 | 1,954,383 | 25,673 | -1.3% | $746.2M | 1.9% | $381.8 |
| Q1 2021 | 1,980,056 | 52,299 | -2.6% | $710.7M | 1.9% | $358.9 |
| Q4 2020 | 2,032,355 | 135,698 | -6.3% | $652.6M | 1.8% | $321.1 |
| Q3 2020 | 2,168,053 | +8,570 | +0.4% | $582.3M | 1.7% | $268.6 |
| Q2 2020 | 2,159,483 | +7,154 | +0.3% | $567.9M | 1.8% | $263.0 |
| Q1 2020 | 2,152,329 | +148,511 | +7.4% | $488.7M | 1.8% | $227.0 |
| Q4 2019 | 2,003,818 | +340,886 | +20.5% | $605.2M | 1.7% | $302.0 |
| Q3 2019 | 1,662,932 | 174,461 | -9.5% | $399.3M | 1.1% | $240.1 |
| Q2 2019 | 1,837,393 | 0 | – | $527.3M | 1.4% | $287.0 |
| Q1 2019 | 1,837,393 | 622,658 | -25.3% | $527.3M | 1.4% | $287.0 |
| Q4 2018 | 2,460,051 | 492,060 | -16.7% | $646.1M | 1.9% | $262.6 |
| Q3 2018 | 2,952,111 | 89,143 | -2.9% | $809.0M | 2.0% | $274.1 |
| Q2 2018 | 3,041,254 | +92,719 | +3.1% | $723.9M | 1.8% | $238.0 |
| Q1 2018 | 2,948,535 | 194,965 | -6.2% | $647.8M | 1.6% | $219.7 |
| Q4 2017 | 3,143,500 | +39,608 | +1.3% | $707.3M | 1.7% | $225.0 |
| Q3 2017 | 3,103,892 | +71,119 | +2.3% | $589.4M | 1.3% | $189.9 |
| Q2 2017 | 3,032,773 | +43,843 | +1.5% | $570.6M | 1.4% | $188.1 |
| Q1 2017 | 2,988,930 | +162,976 | +5.8% | $494.3M | 1.2% | $165.4 |
| Q4 2016 | 2,825,954 | +2,387 | +0.1% | $406.3M | 1.0% | $143.8 |
| Q3 2016 | 2,823,567 | +492,541 | +21.1% | $353.8M | 0.9% | $125.3 |
| Q2 2016 | 2,331,026 | +829,542 | +55.2% | $306.2M | 0.8% | $131.3 |
| Q1 2016 | 1,501,484 | – | – | $208.7M | 0.5% | $139.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did First Eagle Investment Management, LLC first disclose a ELV position in 13F-HR filings?
First Eagle Investment Management, LLC first reported ELEVANCE HEALTH INC FORMERLY (ELV) on its 13F-HR filing for the period ending 2016-03-31 (Q1 2016). The position has appeared on 42 reported quarters within Pactolio's tracked window.
What was First Eagle Investment Management, LLC's most recent quarter-over-quarter share-count change in ELV?
Between Q1 2026 and Q2 2026, First Eagle Investment Management, LLC added 55,905 shares of ELV (+1.4%), bringing the total reported position to 4,188,196 shares at a market value of $1.6B.
Does the implied price-per-share represent First Eagle Investment Management, LLC's cost basis in ELV?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.